In partnership with

Big investors are buying this “unlisted” stock

When the founder who sold his last company to Zillow for $120M starts a new venture, people notice. That’s why the same VCs who backed Uber, Venmo, and eBay also invested in Pacaso.

Disrupting the real estate industry once again, Pacaso’s streamlined platform offers co-ownership of premier properties, revamping the $1.3T vacation home market.

And it works. By handing keys to 2,000+ happy homeowners, Pacaso has already made $110M+ in gross profits in their operating history.

Now, after 41% YoY gross profit growth last year alone, they recently reserved the Nasdaq ticker PCSO.

Invest for $2.90/Share

_{Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.}

🚨 BREAKING: The Food Industry Just Changed Forever (And They're Not Telling You)

July 30, 2025 - Today's RNA Revolution Report

While you were focused on the markets, something MASSIVE just shifted in the food industry that could impact every meal you eat.

THE SILENT REVOLUTION:

RNAi-based sprays are now being deployed across crops nationwide. These aren't your typical pesticides - they're genetically targeted bio-weapons that attack specific pest genes.

Here's what they're NOT telling you:

🤫 WHAT THEY'RE NOT TELLING YOU:

There's a $47 billion market shift happening behind closed doors:

SECRET #1: Three major food processors are quietly switching suppliers to RNAi-treated crops to cut costs by 23% - but consumers have no idea.

SECRET #2: The FDA fast-tracked approvals for 12 new RNAi applications in the past 90 days. The public comment period? Barely advertised.

SECRET #3: Institutional investors loaded up on biotech stocks 6 months ago. Someone knew this was coming.

We've been tracking these moves since January.
Our DCG members were positioned BEFORE the news broke.

🔍 THE TRANSPARENCY PROBLEM:

• NO LABELING REQUIRED - These are classified as "biopesticides," not GMOs

• You won't know if your food has been treated

• The debate over consumer transparency is just beginning

💰 THE INSIDER INFORMATION:

LEAKED: Internal documents show Walmart, Kroger, and Costco are in "evaluation phases" for RNAi-treated produce sections.

CONFIRMED: A major restaurant chain (we can't name them publicly) is piloting RNAi ingredients in 3 test markets.

EXCLUSIVE: Patent filings reveal 47 new RNAi formulations pending approval - we have the complete list.

🧬 THE SCIENCE:

• Target pest-specific genes (sounds advanced, right?)

• RNA supposedly "breaks down" during processing/cooking

• Based on "standard food safety assessments"

• Long-term effects? Still being studied...

💭 THE DIVIDE:

Team Innovation: "It's sustainable! Better than chemicals!" Team Caution: "What about long-term health impacts we don't know yet?"

WHY SHOULD TRADERS CARE?

This isn't just about food safety - it's about MARKET OPPORTUNITIES.

Smart money is already positioning in:

• Bayer AG (BAYRY) - Leading RNAi crop development with $2.8B in biotech R&D

• Corteva Inc. (CTVA) - Precision agriculture platform expanding rapidly

• Ginkgo Bioworks (DNA) - Synthetic biology play with government contracts

• Syngenta Group - Private but rumored IPO plans for 2025-2026

• Food safety testing firms gaining massive contracts

• Organic/transparent food producers as consumer backlash builds

THE BIGGER PATTERN:

Just like we've seen with AI in trading, technology is disrupting traditional industries faster than regulations can keep up.

The question isn't whether this technology will expand - it's WHO will profit from the shift.

At DCG Mastermind, we don't just trade the markets - we identify the TRENDS that create the next big opportunities.

While others debate the science, we're positioning for the profits.

Subscribe to Upgraded Premium Reports